MedTrace Logo

Added Value of Local Clonidine for Spine Postoperative Pain Control, in Addition to Bupivacaine

NCT01902108 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2015-12-08

No results posted yet for this study

Summary

The objective of this prospective randomized double-blind study is to evaluate the added analgesic value of clonidine to the conventional local bupivacaine wound infiltration in posterior spine surgery.

Conditions

  • Post-operative Pain

Interventions

DRUG

Bupivacaine

Local infiltration before wound incision with 20 ml of Bupivacaine 0.25 % alone

DRUG

Clonidine

Clonidine 150μg locally infiltrated with 20 ml of bupivacaine 0.25 % before wound incision

Sponsors & Collaborators

  • St Joseph University, Beirut, Lebanon

    lead OTHER

Principal Investigators

  • Joseph Maarrawi, MD, PhD · Laboratory of neurosciences, Faculty of medicine, St Joseph University of Beirut

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01902108 on ClinicalTrials.gov